Earnings
ADPT
39.75
+3.52%
1.35
Currencies: USD
Items
Total Revenue
Revenue
Cost of Revenue
Gross Profit
Marketing and Administrative Expenses
Research and Development Costs
Financial Expenses
Depreciation and Amortization
Other Expenses
Total Operating Expenses
Asset Impairments
Operating Income
Interest Income
Assets Disposal
Other Non-operating Net Income
Non-operating Income
Net Income Before Taxes
Provision for Income Taxes
Net Income
Minority Interests
Net Income Attributable to Shareholders
Net Income Attributable to Common Equities
Net Income from Discontinued Operations
Basic EPS
Diluted EPS
FY 2020-12-31
98.38M
98.38M
22.53M
75.85M
110.89M
116.07M
--
--
--
251.20M
--
-152.82M
6.59M
--
--
--
-146.23M
--
-146.23M
--
-146.23M
-146.23M
--
--
-1.11
FY 2019-12-31
85.07M
85.07M
22.27M
62.80M
68.78M
70.70M
--
--
--
163.46M
--
-78.39M
9.79M
--
--
--
-68.61M
--
-68.61M
--
-68.61M
-69.57M
--
--
-0.56
FY 2018-12-31
55.66M
55.66M
19.67M
35.99M
44.90M
39.16M
--
--
--
105.42M
--
-49.76M
3.31M
--
--
--
-46.45M
0.00
-46.45M
--
-46.34M
-46.34M
0.00
--
-0.39
FY 2017-12-31
38.45M
38.45M
15.68M
22.77M
32.71M
32.00M
--
--
--
82.92M
--
-44.48M
1.64M
--
--
--
-42.83M
--
-42.83M
--
-42.83M
-42.70M
--
--
-0.36

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out ADPT latest quarterly and annual financial reports. There are also past financial reports for you to reference. You can analyze Adaptive Biotechnologies recent business situations from balance sheets, income statements, cash flow statements and other tables. This information may help you make smarter investment decisions.